Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISTRAL mistletoe therapy in inoperable pancreatic cancer
2014-004552-64Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pancreatic cancer (PC) comparing Mistletoe extract with Placebo (2 arms). Primary endpoint: Overall survival. Started Jan 2016; status: completed.
02
Drugs
viscum album extract
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2014-004552-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004552-64.